N
NeoLight
Medical device company that develops phototherapy beds to cure jaundice in pre-term and full term babies
About NeoLight
NeoLight is a babytech company focused on delivering innovative, family-friendly products that empower parents to confidently care for their newborns. Operating in the neonatal medical care market, NeoLight serves parents and healthcare providers by offering advanced phototherapy systems designed for home or bedside use. The company's flagship product, the Skylife Phototherapy System, provides effective jaundice treatment without the need for NICU incubation, thereby keeping families together and reducing hospital readmissions. NeoLight's business model includes offering their phototherapy systems on loan with no commitment for 30 days, allowing parents to use the technology as needed and return it when no longer required. The company generates revenue through the sale and rental of their phototherapy devices, as well as through partnerships with healthcare institutions. NeoLight's technology also includes real-time monitoring features, ensuring accurate interventions and optimal neonatal care.
Source: Dealroom company dataAt a glance
- Founded
- 2016
- Headquarters
- Scottsdale, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Institute for Commercialization of Florida Technology
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NeoLight on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NeoLight on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.